InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
21%
T+90 mean return
-10.0%
Across 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Campbell Chad Thomas, Chief Executive Officer. Director active across 1 company, notably Angiodynamics INC. Aggregated, 26 reports have been logged. History available since 14 July 2021. The latest transaction was filed on 21 July 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations26 total
1,025 shares@ US$8.692.0% of flowCommon StockSEC:0001140361-25-026796:0
359 shares@ US$8.690.7% of flowCommon StockSEC:0001140361-25-026796:1
395 shares@ US$8.990.8% of flowCommon StockSEC:0001140361-25-026796:2
6,600 shares0Common StockSEC:0001140361-24-035598:0
359 shares@ US$7.130.6% of flowCommon StockSEC:0001140361-24-034272:0
1,025 shares@ US$7.181.8% of flowCommon StockSEC:0001140361-24-033783:0
12,350 shares0Common StockSEC:0001140361-24-033637:0
8,610 shares0Common StockSEC:0001140361-23-044835:0
3,900 shares0Common StockSEC:0001140361-23-036320:0
359 shares@ US$8.740.7% of flowCommon StockSEC:0001140361-23-036116:0
395 shares@ US$8.650.8% of flowCommon StockSEC:0001140361-23-036116:1
11,384 shares0Common StockSEC:0001140361-23-035730:0
596 shares@ US$9.631.3% of flowCommon StockSEC:0001140361-23-035085:0
279 shares@ US$9.560.6% of flowCommon StockSEC:0001140361-23-035085:1
3,987 shares0Common StockSEC:0001567619-22-014377:0
3,104 shares0Common StockSEC:0001567619-22-013848:0
10,748 shares@ US$16.590.035% mcap44.3% of flowCommon StockSEC:0001567619-21-017999:0
10,748 shares@ US$16.5940.2% of flowCommon StockSEC:0001567619-21-017999
8,210 shares0Common StockSEC:0001567619-21-016025:0
8,210 shares0Common StockSEC:0001567619-21-016025
2,395 shares0Common StockSEC:0001567619-21-015950:0
2,395 shares0Common StockSEC:0001567619-21-015950
318 shares@ US$26.101.8% of flowCommon StockSEC:0001567619-21-014063
318 shares@ US$26.100.0016% mcap2.0% of flowCommon StockSEC:0001567619-21-014063:0
571 shares@ US$26.433.3% of flowCommon StockSEC:0001567619-21-013920
25 of 26 declarations
About Campbell Chad Thomas
Chad Thomas Campbell is the Senior Vice President and General Manager of Vascular Access at AngioDynamics Inc. He is responsible for the strategic and operational leadership of the division, contributing to the innovation and expansion of the company's products in the vascular access field. His expertise in management and product development is essential for achieving the company's growth objectives.
